|
Report Date : |
12.04.2013 |
IDENTIFICATION DETAILS
|
Name : |
COPAD EGYPT FOR TRADE AND PHARMACEUTICAL INDUSTRIES |
|
|
|
|
Registered Office : |
Masaken Sheraton, Plot 4, Square 1169, Heliopolis Cairo |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Year of Incorporation : |
1991 |
|
|
|
|
Com. Reg. No.: |
268677 |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Distributors of pharmaceutical preparations. |
|
|
|
|
No. of Employees : |
250 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2011) |
Current Rating (30.06.2012) |
|
Egypt |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EGYPT - ECONOMIC OVERVIEW
Occupying the northeast corner of the African continent, Egypt is bisected by the highly fertile Nile valley, where most economic activity takes place. Egypt's economy was highly centralized during the rule of former President Gamal Abdel NASSER but opened up considerably under former Presidents Anwar EL-SADAT and Mohamed Hosni MUBARAK. Cairo from 2004 to 2008 aggressively pursued economic reforms to attract foreign investment and facilitate GDP growth. Despite the relatively high levels of economic growth in recent years, living conditions for the average Egyptian remained poor and contributed to public discontent. After unrest erupted in January 2011, the Egyptian Government drastically increased social spending to address public dissatisfaction, but political uncertainty at the same time caused economic growth to slow significantly, reducing the government's revenues. Tourism, manufacturing, and construction are among the hardest hit sectors of the Egyptian economy, and economic growth is likely to remain slow at least through 2012. The government is utilizing foreign exchange reserves to support the Egyptian pound and Egypt may seek a loan from the International Monetary Fund.
Source
: CIA
Company Name : COPAD EGYPT FOR TRADE AND PHARMACEUTICAL INDUSTRIES
Country of Origin : Egypt
Legal Form : Egyptian Joint Stock Company
Registration Date : 1991
Commercial Registration Number : 268677
Tax Card Number : 332-326-543
Issued Capital : £E 29,800,000
Paid up Capital : £E 29,800,000
Total Workforce : 250
Activities : Distributors of pharmaceutical preparations.
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
COPAD EGYPT FOR TRADE AND PHARMACEUTICAL INDUSTRIES
Location : Masaken
Sheraton, Plot 4, Square 1169, Heliopolis
Town : Cairo
Country : Egypt
Telephone : (20-2) 22689214
/ 22689212
Facsimile : (20-2)
22689210
Email : eng_khaledali@hotmail.com
Subject operates from a large suite of offices that are rented and
located in the Central Business Area of Cairo.
Branch Office (s)
Location Description
· Industrial Zone,
Plot No. 12011 Factory
premises
Cairo / Ismailia
Road
El Obour
Cairo
Tel: (20-2)
46652445
Fax: (20-2)
46652449
· 11 Emad El Din
Street Office
premises El Azbakia
Cairo
Tel: (20-2)
25897719 / 25892030
Fax: (20-2)
25890250
Name Position
· Mahmoud Hosny Abd
El Kader Chairman
· Ahmed Mahmoud
Hosny Abd El Kader Vice
Chairman
· Emad Abd El Moniem Finance
Manager
· Khaled Ali Mohamed General
Manager
Date of
Establishment : 1991
Legal Form : Egyptian Joint
Stock Company
Commercial Reg.
No. : 268677
Tax Card No. : 332-326-543
Issued Capital : £E 29,800,000
Paid up Capital : £E 29,800,000
· Ahmed Mahmoud
Hosny Abd El Kader 66%
· Mahmoud Hosny Abd
El Kader 12%
· Wedad Mahmoud
Hosny 12%
· Mahmoud Hosny 10%
Activities: Engaged in the import and distribution of pharmaceutical preparations.
Import Countries: France, China, India, Netherlands and Germany.
Agencies Held:
· Expanscience
· Pharmachemi
· Lundbeck
Operating Trend: Steady
Subject has a workforce of approximately 250 employees.
Financial highlights provided by local sources are given below:
Currency: Egyptian Pounds (£E)
Year
Ending 31/12/11: Year Ending
31/12/12:
Total Sales £E
37,500,000 £E
39,000,000
Local sources consider subject’s financial condition to be Fair.
The above financial figures are based on estimations by our local
sources.
·
Commercial International Bank (CIB)
Nile Tower Building
21-23 Giza Street
PO Box: 2430
Cairo
Tel: (20-2) 25703043
Fax: (20-2) 25703172 / 25072691
No complaints regarding subject’s payments have been reported.
During the course of this investigation nothing detrimental was
uncovered regarding subject’s operating history or the manner in which payments
are fulfilled. As such the company is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.53 |
|
|
1 |
Rs.83.59 |
|
Euro |
1 |
Rs.71.33 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.